Clemondo Group AB (publ) (STO:CLEM)
Sweden · Delayed Price · Currency is SEK 7.08
-0.02 (-0.28%)
Aug 13, 2026, 5:13 PM CET
Clemondo Group AB Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 294.4 | 294.4 | 266.73 | 286.24 | 304.13 | 304.96 |
Revenue Growth | 10.34% | 10.37% | -6.82% | -5.88% | -0.27% | -16.20% |
Gross Profit Gross Profit Growth | 115.19 | 115.19 | 102.23 | 107.97 | 104.41 | 126.33 |
Operating Income Operating Income Growth | 8.69 | 8.69 | 9.17 | 16.38 | 7.42 | 23.44 |
Net Income Net Income Growth | 5.51 | 5.51 | 6.17 | 9.96 | 3.76 | 17.02 |
Earnings Per Share EPS Growth | 0.40 | 0.40 | 0.45 | 0.72 | 0.30 | 1.30 |
EPS Growth | -20.00% | -11.11% | -37.50% | 140.00% | -76.92% | -53.57% |
| Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Vehicles Vehicles Growth | 93.38 | 93.48 | 86.88 |
Medical Care Medical Care Growth | 114.97 | 109.79 | 92.91 |
Industry Industry Growth | 27.02 | 27.3 | 21.88 |
Contractual Manufacturing Contractual Manufacturing Growth | 59.8 | 60.63 | 60.4 |
Total Total Growth | 295.16 | 291.21 | 262.06 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0 | 0 | 0 | 1.13 | 0 | 1.09 |
Total Debt Total Debt Growth | 49.51 | 47.11 | 22.46 | 29.67 | 53.03 | 65.13 |
Net Cash (Debt) Net Cash Growth | -49.51 | -47.11 | -22.46 | -28.54 | -53.03 | -64.04 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.58 | -3401.82 | -1621.80 | -2.06 | -3.89 | -4827.38 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 14.04 | 14.04 | 9.82 | 27.2 | 9.1 | 28.23 |
Capital Expenditures CapEx Growth | -0.34 | -0.34 | -1.89 | -0.29 | -0.49 | -1.1 |
Free Cash Flow Free Cash Flow Growth | 13.7 | 13.7 | 7.94 | 26.91 | 8.61 | 27.13 |
Free Cash Flow Growth | -58.73% | 72.67% | -70.51% | 212.66% | -68.28% | -57.75% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.13% | 39.13% | 38.33% | 37.72% | 34.33% | 41.42% |
Operating Margin | 2.95% | 2.95% | 3.44% | 5.72% | 2.44% | 7.69% |
Pretax Margin | 2.48% | 2.48% | 3.06% | 4.60% | 1.55% | 7.02% |
Profit Margin | 1.87% | 1.87% | 2.31% | 3.48% | 1.24% | 5.58% |
FCF Margin | 4.65% | 4.65% | 2.97% | 9.40% | 2.83% | 8.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 29.26 | 22.00 | 15.07 | 12.36 | 27.67 | 11.46 |
Forward PE | 39.44 | 13.09 | 8.22 | 7.91 | 15.81 | 13.33 |
P/FCF Ratio | 13.39 | 0.01 | 11.83 | 4.58 | 13.35 | 7.29 |
PS Ratio | 0.33 | 0.00 | 0.35 | 0.43 | 0.38 | 0.65 |